Genetic Testing Market by Type, Technology, Geography and Forecast to 2024

Biotechnology
Genetic Testing Market Size, Share,
Growth Drivers and Forecast Report 2024
© P&S Intelligence. All rights reserved
1

The global genetic testing market size is projected to grow considerably in
the coming years, due to the growing number of test to study multiple genes
that may help in managing individual health condition. Additionally, the
government initiatives to spread awareness with respect to the advantages
of procedure is further expected to drive the growth of the market. The
market is categorized into carrier testing, diagnostic testing, new-born
screening, predictive & pre-symptomatic testing, prenatal testing, based on
types of gene testing. Among the various types, new born screening held the
largest share in 2016, due to the growing number of newborn genetic
screening programs, while carrier testing is expected to project the fastest
growth in demand during the forecast period.
The different technologies used for genetic testing include cytogenetic
testing, molecular testing, and biochemical testing. Molecular testing was the
most widely utilized technology used for testing and analysis of genes, and
held the largest share in the global market, in 2016. This leading position of
the category is mainly attributable to the increasing analysis on the biological
markers in the genome and proteome studies.
Download report sample at: https://www.psmarketresearch.com/marketanalysis/genetic-testing-market/report-sample
North America was the largest contributor to the market in 2016. According
to the NCBI repository that maintains Genetic Testing Registry(GTR)data from
505 lab participants worldwide, the U.S. leads with 259 labs contributions.
Some of the key factors leading to the growth of the market in the region are
the presence of large number of academic and research institutes, rising
government funding, and availability of technologically advanced products.
However, Asia-Pacific is expected to witness the fastest growth in the genetic
testing market during the forecast period. The major factors driving the
region’s growth include increasing awareness about the advantages of
predictive testing, and rise in the adoption of advanced technology for clinical
applications.
© P&S Intelligence. All rights reserved
2

Increasing application of the gene testing in oncological research, rising
incidences of genetic disorders, technological advancements and rising
demand for personalized medicine are the major drivers augmenting the
growth of the genetic testing industry.
According to the WHO, sickle cell anemia is one of the genetic disorders
particularly common among people whose ancestors come from Sub-Saharan
Africa, South America, Cuba, Central America, Saudi Arabia, India, and
Mediterranean countries such as Turkey, Greece, and Italy. However, high
cost involves in gene testing, and lack of the experienced professionals are
the key factors hampering the growth of the genetic testing market.
Major players in the genetic testing market are Transgenomic, Inc., GE
Healthcare, 23 & Me Sequenom, Inc., Abbott Laboratories, Biocartis SA,
Illumina Inc., 454 Life Sciences, Bio-Rad Laboratories, Luminex Corporation,
Affymetrix Inc., Agilent Technologies Inc., Cephide Inc., Beckman Coulter Inc.
Browse full report at: https://www.psmarketresearch.com/marketanalysis/genetic-testing-market
Genetic Testing Market Segmentation
By Type
Carrier Testing
Diagnostic Testing
New-born Screening
Predictive and Pre-Symptomatic Testing
Prenatal Testing
By Technology
Cytogenetic Testing
Molecular Testing
Biochemical Testing
By Clinical Indication
Alzheimer's Disease
Cancer
Cystic Fibrosis
Sickle Cell Anaemia
Duchenne's Muscular Dystrophy
© P&S Intelligence. All rights reserved
3

Thalassemia
Huntington’s Disease
Others
By Region
North America
o U.S.
o Canada
Europe
o Germany
o U.K.
o France
o Italy
o Spain
o Rest of Europe
Asia-Pacific
o Japan
o China
o India
o Rest of Asia-Pacific
Latin America
o Brazil
o Mexico
o Rest of Latin America
Middle East & Africa (MEA)
© P&S Intelligence. All rights reserved
4

Disclaimer:
P&S Intelligence always keeps its customers’ interests at the core while carrying out research
activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in
its market research publications. However, the information in publications is subject to fluctuations,
as it is based on primary interviews of officials from various companies or organizations. P&S
Intelligence is not responsible for any incorrect data provided by the key industry players of the
concerned domain. The information or analysis in P&S Intelligence publications represents opinions
based on research and should not be interpreted as statements of fact. Information in this report
was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence
does not endorse any product, service, or vendor depicted in its research publications.
All intellectual properties, including trademarks and copyrights, belong to their respective owners
and may be protected by copyright. Under no circumstance can these be reproduced in any form
without prior written agreement of their owners.
An order for market research report is intended for internal use of the company only and not for
disclosure to third parties or any other publication in general. No service, report, or part thereof
provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed,
circulated, or sublicensed in any medium or form now realized or hereafter become realized,
including but not limited to, all forms of optical-based media, magnetic, electronic, or digital,
without a written permission from Prescient & Strategic Intelligence Pvt. Ltd.
Kindly write to: enquiry@psmarketresearch.com
B-13, Sector – 2, Noida, U.P. – 201301, INDIA
Contact No: +91 120 4541 337
US/Canada Toll-Free: 1-888-778-7886
© P&S Intelligence. All rights reserved
5